1. Knowledge
1.1. Describe and state the fundamental sciences courses that is needed for the application of these sciences to drug therapy and human health.
1.2. List and recall the principles of therapeutics, evidence-based, communication, economics, psychology, ethics, pharmacy law and legal issues needed for the practice of pharmacy.
1.3. Outline the structure and drug activity relationship, the basic principles of drug design, analysis and formulation of pharmaceutical dosage forms, drug discovery and complementary medicine, and chemotherapy in order to standardize medicines for administration by different delivery routes to achieve efficient and optimal patient centred care
2. Cognitive Skills
2.1. Integrate knowledge from fundamental sciences to explain how specific drugs or drug classes work and evaluate their potential value in individuals and populations
2.2. Apply principles of pharmacy profession, drug analysis and synthesis, finance, marketing and human resources to manage medication use systems
2.3. Critically analyze scientific literature and technologies related to pharmacy to apply the principles of research in pharmaceutical project.
2.4. Develop and provide an evidence-based approach that considers the cost, care, access, and satisfaction needs of a targeted patient population.
3.Interpersonal Skills & Responsibility
3.1. Exhibit professional ethics, attitudes and behaviors by demonstrating patient advocacy, altruism, accountability, compassion, integrity and respect for others.
3.2. Demonstrate ability to participate and engage as a healthcare team member by demonstrating mutual respect, understanding, and shared goals and values to meet patient care needs.
4.Communication, Information Technology, Numerical
4.1. Demonstrate effective communication skills (verbal, nonverbal, and written method) when interacting with others (patients, healthcare providers and public) to establish rapport and build trusting relationship.
4.2. Integrate information management systems to access scientific information and provide pharmaceutical care.
4.3. Use mathematical & statistical methods for illustration of instrumental analysis to apply in forensics and bio-analysis
5. Psychomotor skills
On completion of program the graduate will be able to:
5.1. Provide pharmaceutical services and participate in drug manufacturing and distribution process.
5.2. Provide patient-centered care to diverse patients using the best available evidence/technology and in consideration of patients’ circumstances to devise, modify, implement, document and monitor pharmacotherapy care plans, either independently or as part of healthcare teams to achieve the optimum safety and efficacy of medication use systems.
5.3. Perform new drugs screening, drug analysis, drug design and identification of infectious diseases.
SEMESTER | SEMESTER 1 | SEMESTER 2 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8* | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25* | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
COURSES |
ARABIC LANGUAGE-I [ARAB 101] 2 CR (2+0+0) | END OF SEMESTER EXAM | ARABIC LANGUAGE-II [ARAB 103] 2 CR (2+0+0) | END OF SEMESTER EXAM | ||||||||||||||||||||||||||||||
ENGLISH LANGUAGE-I [ENGL 101] 6 CR (6+0+0) | ENGLISH LANGUAGE-II [ENGL 102] 3 CR (2+1+0) | |||||||||||||||||||||||||||||||||
MEDICAL TERMINOLOGY [ARAB 105] 2 CR (2+0+0) | BIOLOGY [BIOL 101] 4 CR (3+1+0) | |||||||||||||||||||||||||||||||||
BIOSTATISTICS [BIOS 101] 2 CR (2+0+0) | INTRODUCTION TO CHEMISTRY [CHEM 101] 4 CR (3+1+0) | |||||||||||||||||||||||||||||||||
COMPUTER FOR HEALTH SCIENCES-I [COMP 101] 2 CR (1+1+0) | GENERAL PHYSICS [PHYS 101] 3 CR (2+1+0) | |||||||||||||||||||||||||||||||||
ISLAMIC CULTURE [ISLM 101] 2 CR (2+0+0) | COMMUNICATION SKILLS [COMM 201] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
TOTAL 16 CR | TOTAL 18 CR |
SEMESTER | SEMESTER 1 | SEMESTER 2 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8* | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25* | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
COURSES | ANATOMY [ANAT 223] 3 CR (2+1+0) | END OF SEMESTER EXAM | BIOCHEMISTRY-II [BIOC 204] 3 CR (2+1+0) | END OF SEMESTER EXAM | ||||||||||||||||||||||||||||||
BIOCHEMISTRY-I [BIOC 201] 2 CR (2+0+0) | PHARMACEUTICAL ANALYTICAL CHEMISTRY [PHCH 212] 4 CR (3+1+0) | |||||||||||||||||||||||||||||||||
ECONOMIC SYSTEM IN ISLAM [ISLM 103] 2 CR (2+0+0) | INTRODUCTION TO MEDICINAL CHEMISTRY [PHCH 214] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
MATHEMATICS FOR PHARMACY [MATH 201] 2 CR (2+0+1) | INTRODUCTION TO PHARMACY PROFESSION [PHCL 242] 1 CR (1+0+0) | |||||||||||||||||||||||||||||||||
PHARMACEUTICAL ORGANIC CHEMISTRY [PHCH 211] 4 CR (3+1+0) | GENERAL IMMUNOLOGY [PHCT 232] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PHYSIOLOGY-I [PHSL 205] 3 CR (2+1+0) | PHARMACEUTICAL MICROBIOLOGY [PHCT 234] 3 CR (2+1+0) | |||||||||||||||||||||||||||||||||
PHYSIOLOGY-II [PHSL 206] 2 CR (2+0+0) | ||||||||||||||||||||||||||||||||||
TOTAL 16 CR | TOTAL 14 CR |
SEMESTER | SEMESTER 1 | SEMESTER 2 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8* | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25* | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
COURSES | COMPUTER FOR HEALTH SCIENCES-II [COMP 201] 2 CR (1+1+0) | END OF SEMESTER EXAM | MEDICINAL CHEMISTRY-I [PHCH 316] 3 CR (2+1+0) | END OF SEMESTER EXAM | ||||||||||||||||||||||||||||||
DRUG DISCOVERY AND DEVELOPMENT [PHCH 311] 1 CR (1+0+0) | PATHOPHYSIOLOGY-I [PHCL 342] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
MEDICINAL CHEMISTRY AND MOLECULAR PHARMACOLOGY-I [PHCH 313] 3 CR (3+0+0) | PATIENT ASSESSMENT [PHCL 344] 1 CR (0+1+0) | |||||||||||||||||||||||||||||||||
NATURAL PRODUCTS [PHCH 315] 3 CR (2+1+0) | ALTERNATIVE MEDICINE [PHLG 326] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PHARMACY PRACTICE [PHCL 341] 2 CR (2+0+0) | CHEMOTHERAPY [PHLG 324] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PHARMACEUTICS-I [PHCT 331] 3 CR (2+1+0) | PHARMACEUTICS-II [PHCT 332] 3 CR (2+1+0) | |||||||||||||||||||||||||||||||||
PHARMACOLOGY-I [PHLG 321] 4 CR (3+1+0) | PHARMACOLOGY-II [PHLG 322] 4 CR (3+1+0) | |||||||||||||||||||||||||||||||||
TOTAL 18 CR | TOTAL 17 CR |
SEMESTER | SEMESTER 1 | SEMESTER 2 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8* | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25* | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
COURSES | MEDICINAL CHEMISTRY AND MOLECULAR PHARMACOLOGY-II [PHCH 411] 2 CR (2+0+0) | END OF SEMESTER EXAM | MEDICINAL CHEMISTRY-II [PHCH 412] 3 CR (3+0+0) | END OF SEMESTER EXAM | ||||||||||||||||||||||||||||||
PATHOPHYSIOLOGY-II [PHCL 441] 2 CR (2+0+0) | PHARMACOPEIAL ANALYSIS [PHCH 414] 4 CR (3+1+0) | |||||||||||||||||||||||||||||||||
PHARMACOTHERAPY-I [PHCL 443] 3 CR (3+0+0) | PHARMACOTHERAPY-II [PHCL 444] 3 CR (3+0+0) | |||||||||||||||||||||||||||||||||
PHARMACEUTICS-III [PHCT 431] 3 CR (2+1+0) | DRUG AND POISON INFORMATION SERVICES [PHCL 442] 2 CR (1+1+0) | |||||||||||||||||||||||||||||||||
BASIC PHARMACOKINETICS [PHCT 443] 2 CR (2+0+0) | PHARMACEUTICAL BIOTECHNOLOGY [PHCT 432] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PHARMACOLOGY-III [PHLG 421] 2 CR (2+0+0) | PHARMACOLOGY-IV [PHLG 424] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
TOXICOLOGY [PHLG 423] 3 CR (3+0+0) | BIOPHARMACEUTICS [PHCT 434] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
TOTAL 17 CR | TOTAL 18 CR |
SEMESTER | SEMESTER 1 | SEMESTER 2 | ||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8* | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25* | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 |
COURSES | ETHICS IN PHARMACY [ISLM 401] 2 CR (2+0+0) | END OF SEMESTER EXAM | CONTEMPORARY ISLAMIC ISSUES [ISLM 301] 2 CR (2+0+0) | END OF SEMESTER EXAM | ||||||||||||||||||||||||||||||
APPLIED PHARMACOKINESTICS [PHCL 541] 2 CR (2+0+0) | PHARMACY MANAGEMENT [PHCL 544] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PHARMACY LAW [PHCL 543] 1 CR (1+0+0) | EVIDENCE-BASED PHARMACY [PHCL 546] 2 CR (1+1+0) | |||||||||||||||||||||||||||||||||
PHARMACOTHERAPY-III [PHCL 545] 3 CR (3+0+0) | PHARMACOTHERAPY-IV [PHCL 548] 3 CR (3+0+0) | |||||||||||||||||||||||||||||||||
DISPENSING OF MEDICATIONS [PHCT 531] 3 CR (2+1+0) | PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY [PHCL 542] 3 CR (3+0+0) | |||||||||||||||||||||||||||||||||
NUCLEAR PHARMACY [PHCT 533] 2 CR (2+0+0) | SCIENTIFIC WRITING AND SEMINAR [PHLG 522] 2 CR (1+1+0) | |||||||||||||||||||||||||||||||||
DRUGS OF ABUSE [PHLG 521] 2 CR (2+0+0) | OVER-THE-COUNTER DRUGS [PHCT 532] 2 CR (2+0+0) | |||||||||||||||||||||||||||||||||
PSYCHOLOGY AND HEALTH [PSYC 201] 2 CR (2+0+0) | ||||||||||||||||||||||||||||||||||
TOTAL 15 CR | TOTAL 18 CR |
SEMESTER | SEMESTER 1 | SEMESTER 2 | SUMMER | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WEEKS | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 |
CLERKSHIP | Clerkship-I (3 CR) | Clerkship-II (3 CR) | Clerkship-III (3 CR) | Clerkship-IV (3 CR) | Clerkship-V (3 CR) | Clerkship-VI (3 CR) | Clerkship-VII (3 CR) | Clerkship-VIII (3 CR) | Clerkship-IX (3 CR) | Clerkship-X (3 CR) |